GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Payments of Debt

Cytophage Technologies (TSXV:CYTO) Payments of Debt : C$-0.11 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Payments of Debt?

Cytophage Technologies's Payments of Debt for the three months ended in Mar. 2024 was C$-0.11 Mil.

Cytophage Technologies's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.11 Mil.


Cytophage Technologies Payments of Debt Historical Data

The historical data trend for Cytophage Technologies's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Payments of Debt Chart

Cytophage Technologies Annual Data
Trend Dec21 Dec22 Dec23
Payments of Debt
-0.13 -0.15 -

Cytophage Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Payments of Debt Get a 7-Day Free Trial -0.04 -0.04 - - -0.11

Cytophage Technologies Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cytophage Technologies Payments of Debt Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytophage Technologies (TSXV:CYTO) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.

Cytophage Technologies (TSXV:CYTO) Headlines

From GuruFocus

Altamira Therapeutics Provides Year-End 2022 Business Update

By Value_Insider Value_Insider 12-19-2022

Altamira Therapeutics Provides Update on Clinical Trials with Bentrio

By Stock market mentor Stock market mentor 01-24-2023